Novartis AG Reports $2.28 Billion in Q3 Earnings

October 21, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ZURICH, Oct 21 (Reuters) - Switzerland's Novartis AG (NOVN.VX) posted forecast-beating quarterly results as its newest drugs sold well, strengthening its position in the battle for a full takeover of U.S. eyecare group Alcon Inc (ACL.N).

Twitter
LinkedIn
Facebook
Email
Print

Earnings Europe

Novartis